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Objectives: After its reintroduction as an arterial graft in coronary artery surgery, the
radial artery is now established as an alternative arterial conduit, with good early and
midterm patency. However, because of the concern about its vasospasticity, numer-
ous vasodilator strategies have been used. Recently the use of the irreversible
-adrenergic antagonist phenoxybenzamine has been proposed. Although this treat-
ment is effective in eliminating the vasoconstriction mediated by noradrenaline, the
contribution of other circulating vasoconstrictors to vasospasm could be as impor-
tant. This study investigates the response of radial arteries treated with phenoxy-
benzamine to vasoconstrictor stimuli and possible preventative strategies.
Methods: In vitro, sections of radial artery, pretreated with phenoxybenzamine after
harvesting, were stimulated with maximal concentrations of the vasoconstrictors
noradrenaline, vasopressin, angiotensin II, KCl, and endothelin-1. In matched
segments of artery, vasoconstrictor responses were recorded in the presence of
diltiazem, glyceryl trinitrate, and papaverine and compared with phenoxyben-
zamine-treated samples.
Results: Phenoxybenzamine-treated radial artery failed to respond to noradrenaline
but did respond to vasopressin, angiotensin II, endothelin-1, and KCl. Diltiazem was
largely ineffective against contractile stimuli apart from KCl. Glyceryl trinitrate and
papaverine significantly reduced responses to all of the vasoconstrictors tested.
Conclusion: In phenoxybenzamine-treated sections of radial artery, circulating va-
soconstrictor agonists may still contribute to the induction of spasm. Additional
vasodilator strategies may be required to completely prevent vasospasm.
There is increasing evidence that the use of arterial grafts in coronaryartery bypass surgery results in improved patency rates. The radialartery was first suggested by Carpentier and colleagues1 in 1973, butits use was soon abandoned because of unacceptably high early graftfailure attributed to spontaneous contraction or spasm. However,further analysis at 15 years demonstrated that some of the grafts
were disease-free and patent.2 This prompted a reevaluation of the radial artery as
a potential conduit for bypass surgery. So far the results from midterm angiographic
studies have demonstrated patency rates of radial artery grafts superior to the
saphenous vein and almost as good as the internal thoracic artery.3-6 Thus, there has
been an increase in the use of the radial artery in coronary artery bypass surgery.
Unfortunately spasm has been recorded in 4 to 10% of radial artery grafts
immediately after the operation and may be even higher as nonacute cases of spasm
may go undetected.2,5,6 The radial artery is particularly prone to spasm due to its
muscular nature and large medial cross-sectional area as compared with the internal
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thoracic artery.7,8 Improvements in surgical technique and
handling, whereby the radial artery is removed as a pedicle,
have reduced the incidence of vasospasm.2 In addition,
various vasodilator strategies have been proposed, including
phosphodiesterase inhibitors, such as papaverine, amrinone,
and milrinone, and glyceryl trinitrate (nitroglycerine) and
other nitrovasodilators and L-type Ca2 channel blockers,
such as diltiazem, verapamil, and nicardipine.9 These have
been used both alone and in combination but all have the
drawback that the effect is rapidly removed by the circula-
tion. Recently the use of the -adrenoceptor antagonist
phenoxybenzamine has been proposed as an antispasmodic
agent.10 Phenoxybenzamine binds irreversibly to the 1-
adrenoceptor, the dominant adrenoceptor in the radial ar-
tery,11 and thus treatment with this compound renders the
graft insensitive to the increased levels of catecholamines
present in the circulation postoperatively.10 Phenoxyben-
zamine has been suggested as the sole prophylactic strategy
for the prevention of spasm in the radial artery. However,
the levels of several other vasoconstrictors are also in-
creased as a result of surgery, and their contribution to the
development of spasm should not be overlooked.12 Phe-
noxybenzamine also reacts irreversibly with calmodulin, the
protein that integrates the rise in cellular calcium with
contraction, albeit with a lower affinity than its interaction
with the -adrenoceptor.13 We therefore considered estab-
lishing whether the radial artery treated with phenoxyben-
zamine was still capable of responding to other vasocon-
strictors. To determine whether there is a case for the use of
additional vasodilator strategies in phenoxybenzamine-
treated radial artery, we have studied the response of phe-
noxybenzamine-treated sections of radial artery to depolar-
ization, induced by KCl, and to the vasoconstrictors
vasopressin, angiotensin II, and endothelin-1, as well as to
noradrenaline.
We investigated the 3 prophylactic strategies commonly
used to prevent spasm in the radial artery—nitrovasodila-
tors, calcium channel antagonists, and phosphodiesterase
inhibitors—on sections of radial artery pretreated with phe-
noxybenzamine.
Methods
Materials and Solutions
Organ bath contraction studies were carried out in oxygenated
HEPES-buffered-saline (HBS) solution composed of: NaCl, 145
mmol/L; KCl, 2.5 mmol/L; Na2HPO4, 1 mmol/L; MgSO4, 1
mmol/L; HEPES, 10 mmol/L; D-glucose, 10 mmol/L; CaCl2, 1
mmol/L; pH 7.4 at 37°C. Hanks balanced salt solution (HBSS)
containing 4 mmol/L NaHCO3 was made up from powder and was
sterile-filtered before storage at 4°C until use. The following
reagents were obtained from the following companies: Dulbecco’s
modified Eagle medium and HBSS from Life Technologies (Pais-
ley, Scotland); glyceryl trinitrate solution (nitroglycerine) and pa-
paverine solution from DBL (Warwick, United Kingdom) and
Martindale Pharmaceuticals (Romford, United Kingdom); phe-
noxybenzamine solution from Goldshield Pharmaceuticals Ltd,
(Croydon, United Kingdom); diltiazem, arg-vasopressin, angioten-
sin II, and endothelin-1 from Sigma Chemicals (Poole, United
Kingdom). Fresh diltiazem stock solutions were made up before
each experiment. All other chemicals and reagents from Merck Ltd
(Poole, United Kingdom).
Sample Preparation for Surgery
Sections of radial artery, surplus to coronary artery bypass surgery,
were collected from theater with fully informed patient consent
and local ethical committee approval. In theater, radial arteries
were treated with either phenoxybenzamine (1 mg/mL; 3 mmol/L)
in heparinized whole blood or papaverine (0.6 mg/mL; 1.6
mmol/L) in saline solution, depending on the protocol of the
surgeon. Samples of artery used for research were transported in
ice-cold Dulbecco’s modified Eagle medium to the research lab-
oratory.
All phenoxybenzamine-treated samples remained insensitive to
applications of noradrenaline for the duration of our experiments
and no further application of phenoxybenzamine was applied.
Organ Bath Contraction Studies
Samples of artery were transferred to warmed (37°C) HBSS,
trimmed of connective tissue, and cut into 2- to 3-mm rings with
a scalpel. The rings were mounted in 25 mL of HBS between 2 fine
wire stirrups connected to a force transducer and changes in
isometric force were recorded on a Lectromed 5220 medium gain
amplifier, connected to a Lectromed MT6 chart recorder (Lec-
tromed UK Ltd, Letchworth, Hertfordshire, United Kingdom).
Each ring was stretched to a tension at 30 milli-Newtons (mN) for
1 hour, after which tension was adjusted to 10 mN and the rings
left for a further 30 minutes before the addition of agonists. All
rings were stimulated with 60 mmol/L of KCl before testing with
other vasoconstrictors and only rings that responded to KCl were
used for further experimentation. The vasoconstriction induced by
maximal concentrations of vasoconstrictors was examined in the
presence of 3 vasodilator strategies; phosphodiesterase inhibitors,
nitrates, and calcium channel blockers. Maximal concentrations of
agonists were obtained from previously published experimenta-
tion.8,14,15 All data were collected from samples of radial artery
collected from at least 3 separate patients, where “n” refers to the
number of patients studied and are presented as mean  SEM.
Agonist responses in the presence of vasodilator were paired with
responses in the absence of vasodilator. Paired rings were taken
from the same sample of tissue. An initial KCl response was used
to control for variation in contractility between rings from the
same patient. This protocol was adopted to avoid desensitization
due to repeated agonist additions. Statistical analysis was carried
out using a paired t-test (P  .05). Rings were pretreated with
vasodilators for 5 minutes before the agonist addition and during
the agonist response.
Results
Study Samples
Radial artery segments for the organ chamber studies were
taken from 28 patients undergoing coronary artery bypass
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grafting. For samples treated with phenoxybenzamine in
theater, there were 22 patients with a mean age of 62  2
years. To characterize the response to noradrenaline in our
organ bath, samples were also obtained from other surgeons
not using phenoxybenzamine treatment. These samples
were treated with papaverine in theater and were taken from
6 patients with a mean age of 61  4 years. These samples
were used as controls not treated with phenoxybenzamine.
Response to Noradrenaline in Phenoxybenzamine-
Treated Arteries
To examine the effectiveness of phenoxybenzamine treat-
ment on the noradrenaline response in the radial artery, the
response to noradrenaline in sections of radial artery not
treated with phenoxybenzamine in theater were compared
with responses in phenoxybenzamine-treated radial arteries.
Arterial sections not treated with phenoxybenzamine re-
sponded to noradrenaline with a concentration-dependent
increase in vascular tension. Maximal tension was recorded
at 20 mol/L giving a value of 34.0 1.9 mN and a median
effective concentration (EC50) of 1.8  0.6 mol/L (n  6;
Figure 1). At 2 mol/L noradrenaline sections of radial
artery not treated with phenoxybenzamine responded with
an increase in tension from 13.0  0.6 mN to 31.8  2.1
mN (n  6; Figure 2, A). In contrast, phenoxybenzamine-
treated sections of radial artery (n 22) failed to respond to
additions of either 2 or 20 mol/L noradrenaline, when
tested 4 to 5 hours after the initial treatment (Figure 2, B).
This is consistent with a complete and irreversible blockade
of the -adrenergic receptors.
Responses to Vasoconstrictors in Phenoxybenzamine-
Treated Arteries
To examine the effect of phenoxybenzamine on voltage-
operated calcium channels, tension concentration response
curves were obtained for isomolar KCl additions in phe-
noxybenzamine-treated arteries. KCl gave an EC50 of 25.2
 3.6 mmol/L and maximal response of 33.0  2.4 mN (n
 3). To determine whether the radial artery remained
responsive to other vasoconstrictors, their effects on con-
tractility were examined. Phenoxybenzamine-treated rings
of radial artery with a basal tension of 9.8  2.3 mN (n 
22) responded to 100 nmol/L vasopressin, 100 nmol/L an-
giotensin II, and 10 nmol/L endothelin-1 with increases in
tension to 26.7 2.1 mN (n 8), 27.9 2.0 mN (n 13),
and 23.0  1.7 mN (n  5). Representative responses are
shown in Figure 3.
Figure 1. Mean concentration (log10 mol/L) contraction (per-
centage of maximal noradrenaline contraction) curve for nor-
adrenaline in the human radial artery not treated with phenoxy-
benzamine in theater. Symbols represent data averaged from a
group of rings (taken from 6 patients). Vertical error bars are 1
SEM values.
Figure 2. Representative traces showing force induced in the
presence of 2 mol/L noradrenaline in rings of human radial
artery (A) not treated or (B) treated with phenoxybenzamine.
Phenoxybenzamine-treated arteries were further stimulated with
60 mmol/L KCl to demonstrate functional contractility. The pres-
ence of the vasoconstrictor stimulus in the bath solution is
indicated by the horizontal bar. The responses were terminated
by 2 changes of media.
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Reversal of Contraction in Phenoxybenzamine-Treated
Arteries
KCl and angiotensin II–induced contraction was rapidly
reversed by washing. However, vasopressin and endothelin-
1–induced contraction remained sustained for upward of 25
minutes, even in the absence of agonist, and was not re-
versed by washing alone. The addition of glyceryl trinitrate
completely reversed both vasopressin-induced contraction,
in 13.2  1.3 minutes (n  6), and endothelin 1-induced
contraction in 8.9  2.1 minutes (n  4).
The Effect of Vasodilator Strategies on
Vasoconstrictor Responses in Phenoxybenzamine-
Treated Radial Arteries
Finally, the ability of vasoconstrictors to evoke contractile
responses in the presence of various vasodilators was ex-
amined. Depolarization induced by KCl was significantly
reduced by all of the treatments chosen (Figure 4, A).
However, a measurable response was still obtained in the
presence of diltiazem. Angiotensin II and vasopressin re-
sponses were significantly reduced by both papaverine and
glyceryl trinitrate but not by diltiazem (Figure 4, B and C).
Endothelin-1 responses were significantly reduced by all
treatments (Figure 4, D). Papaverine effectively abolished
responses to KCl, endothelin-1, and angiotensin II, where as
glyceryl trinitrate completely abolished responses to only
endothelin-1. Basal tension of 9.8  2.3 mN (n  22) was
not significantly altered by any of the treatments tested.
Therefore, glyceryltrinitrate and papaverine were effective
against all of the vasoconstrictor stimuli chosen whereas
diltiazem had only a limited use in preventing vasoconstric-
tion.
Discussion
Since the initial report by Taggart and colleagues10 that
treatment of the radial artery with phenoxybenzamine com-
pletely and irreversibly blocks the response to noradrena-
line, it has been demonstrated that the effect persists for
several days.16 This is because the smooth muscle cells,
once treated with phenoxybenzamine, must resynthesize the
-adrenergic receptors de novo before the response to nor-
adrenaline can be reestablished.17 Therefore, pretreatment
of the radial artery with phenoxybenzamine leaves the graft
insensitive to the increased levels of noradrenaline circulat-
ing in the immediate postoperative period. This prophylac-
tic strategy against noradrenaline-induced spasm may have
a broader effect, as in addition to its properties as an
Figure 3. Representative traces showing force induced in phenoxybenzamine-treated rings of human radial artery
by the application of (A) 100 nmol/L angiotensin II, (B) 100 nmol/L vasopressin, (C) 60 mmol/L KCl, and (D) 10 nmol/L
endothelin-1. The presence of the agonist in the bath solution is indicated by the horizontal bar and the stimulus
was removed by 2 changes of media.
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irreversible adrenergic receptor antagonist, phenoxyben-
zamine also irreversibly antagonizes the intracellular pro-
tein calmodulin.13 Calmodulin integrates the vasoconstric-
tor-mediated increases in intracellular calcium to activation
of the myosin light chain kinase, resulting in smooth muscle
contraction.18 However, we found that when treated with
phenoxybenzamine, which completely abolishes the re-
sponse to noradrenaline, the radial artery still showed
marked vasoconstriction to endothelin-1, angiotensin II, va-
sopressin, and depolarization induced by KCl. Our results
suggest that any interaction with calmodulin is unlikely to
contribute to an antispasmodic action of phenoxyben-
zamine. This therefore warrants the continued development
of vasodilator strategies for the radial artery.
After the reintroduction of the radial artery in coronary
artery bypass grafting, the improved patency was partially
attributed to the use of systemic diltiazem in the postoper-
ative period.2 It has since been demonstrated that diltiazem
has only a limited effect against KCl and other vasocon-
strictors in the radial artery, at concentrations considered to
be within the physiologic range.19,20 We selected a dose of
diltiazem equivalent to a topical application routinely used
in theater and sufficient to significantly inhibit KCl-induced
contraction.20 We found that at 10 mol/L, diltiazem effec-
tively reduced KCl-induced contraction but could not re-
producibly abolish it and failed to significantly influence the
maximal response of the radial artery to vasopressin and
angiotensin II. Although the response to endothelin-1 was
reduced by diltiazem, there was still a substantial increase in
tension.
In contrast to diltiazem, we found glyceryl trinitrate and
papaverine to have a much broader inhibitory action against
a variety of vasoconstrictor stimuli, blocking responses to
angiotensin II, endothelin-1, vasopressin, and KCl. This is
not surprising as both of these compounds can antagonize
the rise in smooth muscle cell calcium and act directly on
the contractile apparatus. Glyceryl trinitrate increases
smooth muscle nitric oxide. Nitric oxide inhibits receptor-
stimulated calcium release from intracellular stores and
reduces calcium influx by hyperpolarizing the cell mem-
brane or inhibiting the voltage-gated calcium channel.9,21 In
addition, nitric oxide promotes calcium reuptake into the
stores and calcium extrusion, as well as accelerating myosin
light chain phosphorylation.9,22 This effectively means that
glyceryl trinitrate opposes both agonist-mediated contrac-
tion and subsequent sensitization caused by the activation of
Rho kinase. Papaverine acting predominantly as a type III
phosphodiesterase inhibitor raises intracellular cyclic aden-
osine monophosphate, leading to activation of protein ki-
Figure 4. Mean force generated in phenoxybenzamine-treated rings of human radial artery by the application of
(A) 60 mmol/L KCl, (B) 100 nmol/L angiotensin II, (C) 100 nmol/L vasopressin, and (D) 10 nmol/L endothelin-1. Data
were collected in the presence of 0.5 mg/mL (2.2 mmol/L) glyceryl trinitrate (filled bars), 0.5 mg/mL (1.3 mmol/L)
papaverine (open bars), or 4.5 g/mL (10 mol/L) diltiazem (striped bars). Data are presented as percentage of force
generated in patient-matched rings without vasodilator. Vertical error bars are 1 SEM values. *P < .05 from
patient-matched control values, xP < .05 from prestimulus basal values.
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nase A and inhibiting many of the processes antagonized by
nitric oxide.9,22
In our study high doses corresponding to topical appli-
cations were used to evaluate the maximal effect obtainable.
However, even at levels a thousandfold lower than those
used in this study, glyceryl trinitrate has been shown to
reduce the response to KCl and adrenaline by more than
60%.19 A combination of nitrovasodilators, calcium channel
antagonists, and phophodiesterase inhibitors may be addi-
tive, enhancing the efficacy of low doses of either treat-
ment.23,24 Topical papaverine, however, may damage the
endothelium16,24 and may sensitize the artery to vasocon-
strictors25; therefore, the use of other phosphodiesterase
inhibitors such as milrinone may be preferable and may give
similar results.26 All of these treatment strategies require
repeated administration to maintain their beneficial effects.
In contrast, treatment with phenoxybenzamine is irrevers-
ible and therefore requires a single topical application ad-
ministered solely to the grafted artery. An alternative to a
mixed vasodilator strategy may be the development of an
irreversible treatment targeted to one of the signaling path-
ways, linking a rise in intracellular calcium to contraction.
Cardiopulmonary bypass may cause a profound drop in
systemic vascular resistance due to severe vasodilatation,
which results in a low blood pressure in the presence of a
high cardiac output (systemic inflammatory syndrome).
This can be treated with the infusion of either noradrenaline
or vasopressin.27 As has been demonstrated, pretreatment
with phenoxybenzamine will prevent spasm of the radial
artery in the presence of noradrenaline. The use of vaso-
pressin would result in rapid and sustained contraction of
the radial artery, which would not be easily removed by the
circulation. Thus phenoxybenzamine pretreatment would
prevent the spasm caused by noradrenaline used to treat
systemic inflammatory syndrome without compromising the
radial artery graft. However, the use of topical phenoxyben-
zamine as the sole strategy to prevent spasm of the radial
artery is not sufficient. The phenoxybenzamine-treated ra-
dial artery is still capable of substantial contraction in the
presence of other circulating vasoconstrictors. Nitrates or
phosphodiesterase inhibitors may still have a major role to
play in the prevention and treatment of radial artery spasm.
In conclusion, we would recommend that phenoxyben-
zamine should not be used as a sole agent in the prevention
of radial artery spasm after coronary artery bypass graft
surgery. The use of nitrates, phosphodiesterase inhibitors, or
calcium channel blockers may offer further protection
against spasm. There may be a role for a single compound
that will combine all these effects in preventing and treating
spasm in this promising bypass conduit.
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